Neoplasms

All Conditions

Digestive System Diseases

Carcinoma

Carcinoma, Hepatocellular

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Adenocarcinoma

Liver Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Liver Diseases

Infusion SB injection of 21.87 ml/m\^2, IV route, 24 times for 4 months

SB injection

Lee Jin woo, Prof.

Lee Ji yeon, RN/BSc

Lee Jin woo, prof.

Lee Jin woo, prof

The purpose of this study is to determine efficacy of SB injection in Hepatocellular Carcinoma (HCC).

All eligible patients will receive SB injection therapy for 6 cycles (14\~21 days for each cycle). Efficacy wll be evaluated every 3 cycles.

Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)

PhaseⅡ, Open Label, Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma

SBPharmaceutical IND, Co., LTD

Lee Dong-heum / executive director

Colorectal Neoplasms

Intestinal Neoplasms

Colonic Diseases

Intestinal Diseases

Rectal Diseases

Infusion SBinjection of 21.87ml/m\^2, IV route, 24times for 4 months

Yong-oon Shin, Prof.

Ji-yeon Lee, RN/BSc

Yong-oon Shin, Prof

The purpose of this study is to determine efficacy of SB injection in Colorectal Cancer.

All eligible patients will receive SB injection therapy for 6 cycles (14\~21 days for each cycle). Efficacy will be evaluated every 3 cycles.

Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer

Phase Ⅱ,Open Label Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Colorectal Cancer

Respiratory Tract (Lung and Bronchial) Diseases

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Respiratory Tract Neoplasms

Thoracic Neoplasms

Lung Diseases

Respiratory Tract Diseases

Carcinoma, Bronchogenic

Bronchial Neoplasms

Infusion SBinjection of 21.87ml/m\^2, Intravenous route, 16times for 2.5 months

Chae-young Lee, Medical Doctor

A-young Shin, Registered Nurse

Cae-young Lee, MD

Jae-yong Park, Professor

Seung-beom Han, Professor

The purpose of this study is to determine efficacy of SB injection in Non Small Cell Lung Cancer.

All eligible patients will receive SB injection therapy for 4 cycles (14\~21 days for each cycle). SB injection treatment could be continue after completion of therapy cycles until 6th cycle. It depends on the investigator's decision and patient's will. Efficacy will be evaluated every two cycles.

Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer

Phase Ⅱa,Open Label,Multicenter Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer

Rare Diseases

Stomach Neoplasms

Stomach Diseases

Stomach Cancer

The purpose of this study is to determine efficacy of SB injection in Gastric Cancer.

Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer

Phase Ⅱ,Open Label Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Gastirc Cancer

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma (HCC)	NCT01308645	Hepatocellular ...	SB injection	18 Years -	SBPharmaceutical IND, Co., LTD
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer	NCT01305980	Colorectal Canc...	SB injection	18 Years -	SBPharmaceutical IND, Co., LTD
Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer	NCT01305967	Non Small Cell ...	SB injection	18 Years - 70 Years	SBPharmaceutical IND, Co., LTD
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer	NCT01305993	Gastric Cancer	SB injection	18 Years -	SBPharmaceutical IND, Co., LTD
Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer	NCT01305967	Non Small Cell ...	SB injection	18 Years - 70 Years	SBPharmaceutical IND, Co., LTD
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer	NCT01305980	Colorectal Canc...	SB injection	18 Years -	SBPharmaceutical IND, Co., LTD
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer	NCT01305993	Gastric Cancer	SB injection	18 Years -	SBPharmaceutical IND, Co., LTD
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Colorectal Cancer	NCT01305980	Colorectal Canc...	SB injection	18 Years -	SBPharmaceutical IND, Co., LTD
Investigation of Safety and Efficacy of SB Injection in Patients With Advanced and Metastatic Non-small Cell Lung Cancer	NCT01305967	Non Small Cell ...	SB injection	18 Years - 70 Years	SBPharmaceutical IND, Co., LTD

Spots Global Cancer Trial Database for sb injection

Every month we try and update this database with for sb injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.